<DOC>
	<DOCNO>NCT01075529</DOCNO>
	<brief_summary>The purpose study identify degree symptom change early week could use predict eventual nonresponse week 6 among depressive inpatient take fluoxetine .</brief_summary>
	<brief_title>Early Prediction Fluoxetine Response</brief_title>
	<detailed_description>Patients major depressive disorder receive 20 mg/day fluoxetine six week . Symptom severity assess 17-item Hamilton Depression Rating Scale ( HAMD-17 ) week 0 , 1 , 2 , 3 , 4 6 . Stable response define reduction 50 % HAMD-17 score week 4 week 6 treatment . Receiver operate characteristic curve use determine cutoff point percentage HAMD-17 score reduction stable responder nonresponders week 1 , 2 , 3 4 .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>diagnosis major depressive disorder HAMD17 â‰§17 write informed consent Comorbid substance abuse/dependence Comorbid mental disorder due general medical condition Past history treatmentresistant depression Severe physical problem pregnant woman lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>major depressive disorder , fluoxetine , Hamilton Rating Scale Depression ( HAM-D-17 )</keyword>
</DOC>